The Recall Desk
HighFDA (Devices)·Z-2245-2021·Announced 2021-08-18

FDA Recalls Blood Culture Identification Panel for False Negative Results

BioFire Diagnostics is recalling 29 FilmArray Blood Culture Identification Panel kits distributed nationwide due to false negative test results caused by a pouch manufacturing error.

What this means for you

Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.

Our severity reasoning: This is an FDA Class II medical device recall with no reported illnesses or injuries. The hazard is diagnostic failure (false negative results), which poses a risk of harm through missed clinical diagnoses. Per the severity rubric, risk-of-harm products where injury has not yet been reported receive a score of 3.

Plain-English summary

BioFire Diagnostics, LLC is recalling 29 FilmArray Blood Culture Identification (BCID) Panel kits (FDA Class II recall). These kits are used to identify bacteria and other microorganisms in blood cultures for diagnostic purposes.

The company received complaints of false negative results (dropouts) with the blood culture identification panel. The issue is potentially caused by a pouch manufacturing error.

The affected kits were distributed nationwide to healthcare facilities in Florida, Michigan, New Jersey, Ohio, Virginia, and Wisconsin. The specific lot numbers are Kit Lot# 0868221, Pouch Lot# 194Z21, and Batch 003.

The recalled product

Product
FilmArray Blood Culture Identification (BCID) Panel Product Pouch Label: FilmArray BCID Panel Part No: RFIT-ASY-0126 Part No: RFIT-ASY-0127
Manufacturer
BioFire Diagnostics, LLC
Hazard
  • false-negative
  • manufacturing-defect

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Part No: RFIT-ASY-0126 / UDI: 00815381020086
  • Part No: RFIT-ASY-0127 / UDI: 00815381020093
  • Kit Lot# 0868221
  • Pouch Lot# 194Z21
  • Batch 003

Distribution

Distributed nationwide across the United States.